QuickView for QIK;jsessionid=4649F6C4366E6517B205BEF9A67A3028;jsessionid=3C7EC6E7D7576D823330E28AF0EFE192;jsessionid=3A79900778BD64AB4A1A7CD7E34E4371 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Omental adipose tissue
Synovial membrane
Adipose tissue subcutaneous
Adipose tissue
Stomach cardiac

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Varicella-zoster virus infection
Gastrointestinal hemorrhage
Muscle cachexia
Physical activity
Pneumonia

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

8-aminohexylamino cAMP
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Flavoxate
Kainate
di-Calciphor

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

LGR4
PPOX
ABCA4
MAD2L1
HEY2

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and gene…
Inhibiting eukaryotic initiation factor 5A (eIF5A) hypusination attenuated activation of the SIK2 (s…
Exploring the stability of inhibitor binding to SIK2 using molecular dynamics simulation and binding…
Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma.
SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for QIK;jsessionid=4649F6C4366E6517B205BEF9A67A3028;jsessionid=3C7EC6E7D7576D823330E28AF0EFE192;jsessionid=3A79900778BD64AB4A1A7CD7E34E4371

Explore Clinical Trials Results